---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-004491"
form_type: "8-K"
ticker: null
cik: "0001783032"
company_name: "Elevation Oncology, Inc."
filed_at: "2025-04-04T23:59:59+00:00"
generated_at: "2026-05-23T21:16:30.685209+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Elevation Oncology to voluntarily prepay $32.2M term loan with K2HV

## Summary
- Principal of $30.0M plus prepayment fee of $300K, final payment $1.935M, and accrued interest.
- Expected prepayment date on or about May 3, 2025.
- Loan agreement originally signed July 27, 2022, amended March 1, 2024.
- Company delivered written notice of election to prepay all outstanding term loan.

## SEC filing metadata
- accession: 0001558370-25-004491
- form_type: 8-K
- cik: 0001783032
- company_name: Elevation Oncology, Inc.
- filed_at: 2025-04-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.04
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1783032/000155837025004491/0001558370-25-004491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1783032/000155837025004491/elev-20250403x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-004491
- JSON: https://secwatch.observer/filing/0001558370-25-004491.json
- Plain text: https://secwatch.observer/filing/0001558370-25-004491.txt

## Key facts
- Debt Financings
  Elevation Oncology, Inc. faced acceleration on term loan of $30.0 million with K2 HealthVentures LLC.
  - Instrument: term loan
  - Principal: $30.0 million
  - Counterparty: K2 HealthVentures LLC
  - Event: acceleration
  source text: Ankura Trust Company, LLC, as collateral agent. ​ Pursuant to the Loan Agreement, the Lenders provided a term loan to the Company in the aggregate original principal amount of $30.0 million (the “Term Loan”). Under the Loan Agreement, the Company has the option to prepay all, but not less than all, of the Term Loan, provided that the Company pays on the date of such
  evidence_url: https://www.sec.gov/Archives/edgar/data/1783032/000155837025004491/0001558370-25-004491-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.